Today: 8 June 2026
Northern Star Resources share price slips after gold’s shock fall; what ASX:NST investors watch next week
31 January 2026
2 mins read

Northern Star Resources share price slips after gold’s shock fall; what ASX:NST investors watch next week

Sydney, Jan 31, 2026, 16:49 AEDT — Market closed

  • On Friday, Northern Star ended the session down 1.87%, closing at A$28.94.
  • The steep sell-off in gold late last week has recalibrated risk heading into Monday’s open.
  • The upcoming catalyst for the company is the half-year results, set for release on Feb. 12.

Northern Star Resources shares slipped 1.87% to close at A$28.94 on Friday, after fluctuating between A$28.30 and A$29.75 during the session. This decline erased much of Thursday’s 3.11% gain. Trading volume hit roughly 13.15 million shares.

This matters now since the stock has turned into a fast barometer for bullion sentiment once more. As the Australian market stays closed over the weekend, investors are eyeing gold prices and the U.S. dollar closely, trying to gauge if Friday’s dip was a simple shakeout or the beginning of a bigger decline.

Gold offered no refuge. Spot gold plunged 9.5% on Friday, retreating sharply after hitting a record high the day before. The sell-off came after Donald Trump announced Kevin Warsh as his pick to lead the Federal Reserve. “Whether we look at the dollar or expectations for real yields, a combination of these drivers has helped trigger profit-taking,” explained Suki Cooper at Standard Chartered Bank. Nicky Shiels from MKS PAMP SA described January as “the most volatile month in precious metals history.” Reuters

The broader market slipped as well. The S&P/ASX 200 dropped 0.65% on Friday, dragged down by miners who had led gains earlier in the week, Morningstar reported alongside Australian Associated Press.

Company fundamentals are still driving results behind the scenes. Northern Star’s December-quarter report last week showed it sold 348,061 ounces of gold at an all-in sustaining cost (AISC) of A$2,937 per ounce, with cash and bullion totaling A$1.176 billion. CEO Stuart Tonkin attributed a “softer December quarter” to “one-off operational events,” while the firm highlighted progress on growth projects and flagged more free cash flow as hedges unwind. NSR Limited

In January, Northern Star trimmed its FY26 production forecast to 1.6–1.7 million ounces from the earlier 1.7–1.85 million ounces. It also raised the FY26 AISC estimate to A$2,600–2,800 per ounce. The company attributed these updates mainly to lower gold sales and increased royalties linked to higher gold prices. Its sustaining capital guidance remained steady at around A$750 million.

AISC is a widely used industry metric that aims to reflect the true cost of ongoing production, beyond just daily mining expenses. It includes sustaining capital and site overheads on top of operating costs, meaning it can spike if output falls or expenses increase.

Gold prices have hovered near record highs this year, but gold equities haven’t consistently matched that momentum. Macquarie points out that many broker models still use long-term gold price assumptions well below current spot levels, limiting upside in target prices. January saw big moves for Evolution Mining, Regis Resources, and Newmont, mirroring bullion’s volatility despite the metal’s strong gains.

There’s a sharper downside to consider as well. If gold keeps sliding and risk appetite worsens, miners tend to tank even more sharply — costs don’t drop as quickly, making it tougher to uphold guidance. Any slip-up before earnings season would only worsen the hit.

Northern Star’s next key milestone is its half-year results on Feb. 12. Until then, Monday’s market open could act as a test of whether last week’s drop in gold continues to weigh on stocks.

Stock Market Today

  • How to Buy SpaceX Stock on Its IPO Day: Key Details for Investors
    June 8, 2026, 10:09 AM EDT. SpaceX is set to go public on Nasdaq on June 12, aiming to raise $75 billion in what would be the largest IPO ever. The IPO price is $135 per share, available mainly to select investors through brokers including Robinhood, SoFi, Charles Schwab, Fidelity, and E*TRADE. Public investors can buy shares under ticker SPCX when trading begins, using market orders for immediate purchase or limit orders to control price. However, acquiring IPO-priced shares isn't guaranteed and depends on broker rules and allocation. For those wary of direct investment risks in the high-reward space sector, exposure via exchange-traded funds (ETFs) with SpaceX holdings is an alternative option.

Latest articles

Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

Corning Wins Amazon AI Fiber Deal; GLW Faces Next Hurdle

8 June 2026
Amazon’s new multibillion-dollar supply deal makes Corning a key fiber provider for U.S. data centers, but with shares up 305% in 12 months and investors already pricing in big AI wins, the stock was little changed at $177.58 premarket as risks of factory delays and high expectations loom.
BlackBerry Shares Stall After QNX Push

BlackBerry Stock Moves in Pre-Market Ahead of June Test

8 June 2026
BlackBerry’s U.S. shares rose 2.34% in premarket trading to $9.63 after Friday’s 8.99% drop, but with analyst targets averaging just $4.98, investors are betting on QNX growth and secure-communications wins ahead of June 25 earnings; any disappointment could hit the stock hard.
Micron Technology Stock Surges as AI Memory Shortage Puts MU at Center of Chip Rally

Micron Shares Edge Up in Premarket; Investors Await Next AI Test

8 June 2026
Micron surged 8.2% to $935.07 in Nasdaq premarket after Friday’s $127 billion rout, as investors cheered Nvidia’s confirmation it will keep sourcing high-bandwidth memory from Micron and Samsung, easing fears SK Hynix would become exclusive supplier; Cantor Fitzgerald raised its price target to $1,500, with Micron’s next earnings report due June 24.
Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

Tango Therapeutics Stock Surges After Cancer Drug Shows 92% Response Rate

8 June 2026
Tango shares soared up to 48% in premarket trading after reporting a 92% objective response rate and 90% six-month progression-free survival in a 12-patient pancreatic cancer trial, with plans to advance the vopimetostat-daraxonrasib combo to Phase 3 testing in first-line MTAP-deleted pancreatic cancer.
Disney stock heads into new week with Iger succession report hanging over DIS shares
Previous Story

Disney stock heads into new week with Iger succession report hanging over DIS shares

Wilmar International share price slips to S$3.39 as palm oil turns lower — what to watch before Feb 26 results
Next Story

Wilmar International share price slips to S$3.39 as palm oil turns lower — what to watch before Feb 26 results

Go toTop